image
Healthcare - Biotechnology - NASDAQ - US
$ 1.085
-12.8 %
$ 247 M
Market Cap
-4.36
P/E
CASH FLOW STATEMENT
-3.47 M OPERATING CASH FLOW
97.82%
29 M INVESTING CASH FLOW
126.15%
-11.5 M FINANCING CASH FLOW
-6.04%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Gossamer Bio, Inc.
image
50m50m00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)(250m)(250m)201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -56.5 M
Depreciation & Amortization 4.15 M
Capital Expenditures 0
Stock-Based Compensation 20.6 M
Change in Working Capital 39.5 M
Others 29.9 M
Free Cash Flow -3.47 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (56.5) (179.8) (229.4) (234.0) (243.4) (180.3) (147.0) (6.8) 83 K
Depreciation & Amortization 4.2 4.4 4.4 5.2 4.3 3.1 0.3 0 0
Deferred Income Tax 0 0 0 0.4 (0.2) (2.4) 0 0 0
Stock Based Compensation 20.6 28.5 42.6 32.0 38.7 20.8 30.9 32 K 0
Other Operating Activities (11.2) 2.6 (0.2) 6.8 27.2 3.8 49.7 32 K 0.1
Change in Working Capital 39.5 (14.8) (4.5) 0.8 (3.1) 10.1 15.0 1.0 0.1
Cash From Operations (3.5) (159.2) (187.0) (188.9) (176.4) (144.8) (51.0) (5.7) 20 K
INVESTING CASH FLOW
Capital Expenditures 0 0 (0.5) (1.6) (24.9) (6.6) (21.2) 0 0
Other Items 29.0 (111.0) (0.6) (115.8) 240.2 (140.6) (123.5) 0 0
Cash From Investing Activities 29.0 (111.0) (1.0) (117.4) 215.3 (147.1) (144.7) 0 0
FINANCING CASH FLOW
Common Stock Repurchased 0.6 0 0 0 0 0 0 0 0
Total Debt Repaid (12.6) (11.6) (5.8) 0 193.6 28.2 40 K 6.0 40 K
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 1.1 0.9 3.0 3.3 1.8 293.4 300.9 0 0
Cash From Financing Activities (11.5) 190.2 117.1 3.3 312.5 321.6 300.9 6.0 40 K
CHANGE IN CASH
Net Change In Cash 14.0 (79.9) (71.5) (303.2) 351.5 29.7 105.1 0.3 0
FREE CASH FLOW
Free Cash Flow (3.5) (159.2) (187.5) (190.5) (201.2) (151.4) (72.3) (5.7) 20 K